TPG's Parkway Health plans several hospitals in India
Introduction
Singapore’s Parkway Health, controlled by the US-based private equity firm Texas Pacific Group (TPG) announced that it has plans to set up several multispeciality hospitals in India. The group is also tying up with some of the leading healthcare providers in India apart from its plans to build hospitals on its own. Currently it has agreement with Apollo Hospitals Group and has bought a 50 per cent stake in the Khubchandani Hospital in Mumbai which is jointly owned by the Mauritius-based Koncentric Investments. It plans to initially invest approximately US$ 83 million (Rs 350-400 crore) in the Mumbai-based Khubchandani Hospital.
Location
Parkway Health plans to set up the multispeciality hospitals all over India.
Budget
The hospital firm plans to invest US$ 125 thousand (Rs 50-60 lakh) per bed in the project.
Features
Starting with 5-6 hospitals in metros, Parkway Health has plans to set up 300-400-bed multispeciality hospitals all over the country.
The Khubchandani Hospital, which will be a 1,000-bed facility, is expected to be operational by 2011. The agreement with Apollo Group is intended to help Parkway develop hospitals across West Bengal. This JV currently runs Apollo Gleneagles Hospital, a 325-bed multispeciality hospital in Kolkota. This hospital will cater to Eastern India and neighbouring countries like Bangladesh, Myanmar, Nepal and Bhutan.
Specifications Table:
- Name
- Parkway Health's Multispeciality Hospitals
- Location
- Spread across India.
- Estimated Cost
- US$ 125 thousand (50-60 lakh) per bed
- Project Starting year
- 2009
- Year of completion
- NA
- Promoter
- Parkway Health
- Construction Type
- New Construction
